{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:25:38Z","timestamp":1789723538791,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,4,12]],"date-time":"2006-04-12T00:00:00Z","timestamp":1144800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00428-006-0198-1","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T16:56:46Z","timestamp":1144774606000},"page":"822-829","source":"Crossref","is-referenced-by-count":13,"title":["Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract"],"prefix":"10.1007","volume":"448","author":[{"given":"Yasuyoshi","family":"Miyata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Nomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomayoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kanetake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,12]]},"reference":[{"key":"198_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-26980-0_14","volume":"166","author":"N Arber","year":"2005","unstructured":"Arber N, Levin B (2005) Chemoprevention of colorectal cancer: ready for routine use? Recent Results Cancer Res 166:213\u2013230","journal-title":"Recent Results Cancer Res"},{"key":"198_CR2","first-page":"1157","volume":"8","author":"T Asano","year":"2002","unstructured":"Asano T, Shoda J, Ueda T, Kawamoto T, Todoroki T, Shimonishi M, Tanabe T, Sugimoto Y, Ichikawa A, Mutoh M, Tanaka N, Miwa M (2002) Expression of cyclooxygenase-1 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin Cancer Res 8:1157\u20131167","journal-title":"Clin Cancer Res"},{"key":"198_CR3","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.2005.09.051","volume":"23","author":"JR Braun","year":"2005","unstructured":"Braun JR, DuBois RN (2005) COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 23:2840\u20132855","journal-title":"J Clin Oncol"},{"key":"198_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1073\/pnas.2535911100","volume":"101","author":"SH Chang","year":"2004","unstructured":"Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T (2004) Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 101:591\u2013596","journal-title":"Proc Natl Acad Sci USA"},{"key":"198_CR5","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1054\/bjoc.2000.1143","volume":"82","author":"Y Chen","year":"2000","unstructured":"Chen Y, Hugh-Fulfold M (2000) Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer. Br J Cancer 82:2000\u20132006","journal-title":"Br J Cancer"},{"key":"198_CR6","first-page":"205","volume":"46","author":"RA Coleman","year":"1994","unstructured":"Coleman RA, Smith WL, Narumiya S (1994) International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205\u2013229","journal-title":"Pharmacol Rev"},{"key":"198_CR7","doi-asserted-by":"crossref","first-page":"20809","DOI":"10.1074\/jbc.C100140200","volume":"276","author":"M Dohadwala","year":"2001","unstructured":"Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM (2001) Non-small cell cancer cyclooxygenase-dependent invasion is mediated by CD44. J Biol Chem 276:20809\u201320812","journal-title":"J Biol Chem"},{"key":"198_CR8","doi-asserted-by":"crossref","first-page":"50828","DOI":"10.1074\/jbc.M210707200","volume":"52","author":"M Dohadwala","year":"2002","unstructured":"Dohadwala M, Bartra RK, Luo J, Lin Y, Krysan K, P\u00f5ld M, Sharma S, Dubinett SM (2002) Autocrine\/paracrine PGE2 production by non-small cell lung cancer cells regulates MMP-2 and CD44 in COC-2 dependent invasion. J Biol Chem 52:50828\u201350833","journal-title":"J Biol Chem"},{"key":"198_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063\u20131073","journal-title":"FASEB J"},{"key":"198_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0302-2838(03)00313-0","volume":"44","author":"P Eschwege","year":"2003","unstructured":"Eschwege P, Ferlicot S, Droupy S, Ba N, Conti M, Loric S, Coindard G, Denis I, Ferretti L, Cornelius A, Legrand A, Bedossa P, Benoit G, Jardin A, Scardiono P (2003) A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder. Eur Urol 44:435\u2013441","journal-title":"Eur Urol"},{"key":"198_CR11","first-page":"403","volume":"62","author":"MB Hansen-Petrik","year":"2003","unstructured":"Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J (2003) Prostaglandin E2 protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in APCmin\/+ mice. Cancer Res 62:403\u2013408","journal-title":"Cancer Res"},{"key":"198_CR12","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0022-5347(01)67395-6","volume":"153","author":"RL Hong","year":"1996","unstructured":"Hong RL, Pu YS, Hsieh TS, Chu JS, Lee WJ (1996) Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. J Urol 153:2025\u20132028","journal-title":"J Urol"},{"key":"198_CR13","first-page":"1863","volume":"8","author":"K Inoue","year":"2002","unstructured":"Inoue K, Kamada M, Salton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CF, Shuin T (2002) The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 8:1863\u20131870","journal-title":"Clin Cancer Res"},{"key":"198_CR14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1054\/bjoc.2001.2033","volume":"85","author":"HN Jabbour","year":"2001","unstructured":"Jabbour HN, Milne SA, Williams AR, Anderson RA, Boddy SC (2001) Expression of COX-2 and PGE synthase and synthesis of PGE(2) in endometrial adenocarcinoma: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors. Br J Cancer 85:1023\u20131031","journal-title":"Br J Cancer"},{"key":"198_CR15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/carcin\/22.12.2001","volume":"22","author":"T Kawamori","year":"2002","unstructured":"Kawamori T, Uchiya N, Nakatsugi S, Watanabe K, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Sugimura T, Wakabayashi K (2002) Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonists, on breast cancer development. Carcinogenesis 22:2001\u20132004","journal-title":"Carcinogenesis"},{"key":"198_CR16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10585-005-1190-x","volume":"21","author":"Y Kinugasa","year":"2004","unstructured":"Kinugasa Y, Hatori M, Ito H, Kurihara Y, Ito D, Nagumo M (2004) Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. Clin Exp Metastasis 21:737\u2013745","journal-title":"Clin Exp Metastasis"},{"key":"198_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9440(10)64513-0","volume":"157","author":"M K\u00f6mhoff","year":"2000","unstructured":"K\u00f6mhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, Koch MO, Shapper SB, Breyer MD (2000) Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 157:29\u201335","journal-title":"Am J Pathol"},{"key":"198_CR18","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1158\/0008-5472.CAN-05-0216","volume":"65","author":"K Krysan","year":"2005","unstructured":"Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM (2005) Prostaglandin E2 activates mitogen-activated protein kinase\/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65:6275\u20136281","journal-title":"Cancer Res"},{"key":"198_CR19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0006-291X(02)02707-9","volume":"299","author":"G Li","year":"2002","unstructured":"Li G, Yang T, Yan J (2002) Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 299:886\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"198_CR20","first-page":"1306","volume":"60","author":"JL Masferrer","year":"2000","unstructured":"Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306\u20131311","journal-title":"Cancer Res"},{"key":"198_CR21","first-page":"1741","volume":"9","author":"Y Miyata","year":"2003","unstructured":"Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H (2003) Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 9:1741\u20131749","journal-title":"Clin Cancer Res"},{"key":"198_CR22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.urology.2003.09.035","volume":"63","author":"Y Miyata","year":"2004","unstructured":"Miyata Y, Shigeru K, Nomata K, Hayashida Y, Kanetake H (2004) Expression of metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 and -2 in transitional cells carcinoma of the upper urinary tract: correlation with tumor stage and survival. Urology 63:602\u2013608","journal-title":"Urology"},{"key":"198_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.ju.0000148272.77539.2d","volume":"173","author":"Y Miyata","year":"2005","unstructured":"Miyata Y, Shigeru K, Nomata K, Eguchi J, Kanetake H (2005) Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract. J Urol 173:56\u201360","journal-title":"J Urol"},{"key":"198_CR24","first-page":"987","volume":"59","author":"SI Mohammed","year":"1999","unstructured":"Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KNM, Masferrer JL, Woerner Snyder PW, Koki AT (1999) Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 59:987\u2013990","journal-title":"Cancer Res"},{"key":"198_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001703-200502000-00009","volume":"17","author":"A Munkarah","year":"2005","unstructured":"Munkarah A, Ali-Fehmi R (2005) COX-2: a protein with an active role in gynecological cancers. Curr Opin Obstet Gynecol 17:49\u201353","journal-title":"Curr Opin Obstet Gynecol"},{"key":"198_CR26","first-page":"28","volume":"62","author":"M Mutoh","year":"2002","unstructured":"Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, Tani K, Kobayashi M, Maruyama T, Kobayashi K, Ohuchida S, Sugimoto Y, Narumiya S, Sugimura T, Wakabayshi K (2002) Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res 62:28\u201332","journal-title":"Cancer Res"},{"key":"198_CR27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<724::AID-CNCR16>3.0.CO;2-#","volume":"82","author":"K Nakanishi","year":"1998","unstructured":"Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma. Cancer 82:724\u2013732","journal-title":"Cancer"},{"key":"198_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0046-8177(00)80219-1","volume":"31","author":"K Nakanishi","year":"2000","unstructured":"Nakanishi K, Kawai T, Sato H, Aida S, Kasamatsu H, Aurues T, Ikeda T (2000) Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract. Hum Pathol 31:193\u2013200","journal-title":"Hum Pathol"},{"key":"198_CR29","first-page":"518","volume":"122","author":"B Rigas","year":"1993","unstructured":"Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122:518\u2013523","journal-title":"J Lab Clin Med"},{"key":"198_CR30","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jcem.86.5.7442","volume":"86","author":"KJ Sales","year":"2001","unstructured":"Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, Millar RP, Jabbour HN (2001) Cyclooxygenase-2 expression and prostaglandin E2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors. J Clin Endocrinol Metab 86:2243\u20132249","journal-title":"J Clin Endocrinol Metab"},{"key":"198_CR31","first-page":"326","volume":"58","author":"H Sheng","year":"1998","unstructured":"Sheng H, Shao J, Morrow JD, Beauchamp RD, Dubois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:326\u2013362","journal-title":"Cancer Res"},{"key":"198_CR32","first-page":"75","volume":"276","author":"H Sheng","year":"2001","unstructured":"Sheng H, Shao J, Washington MK, Dubois RN (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:75\u201381","journal-title":"J Biol Chem"},{"key":"198_CR33","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0002-9440(10)65455-7","volume":"155","author":"V Toma","year":"1999","unstructured":"Toma V, Hauri D, Schmid U, Ackermann D, Maurer R, Alund G, Kn\u00f6nagel H, Rist M, Gasser TC, Sauter G, Roth J (1999) Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinoma. Am J Pathol 155:1427\u20131432","journal-title":"Am J Pathol"},{"key":"198_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-004-1105-2","volume":"445","author":"D Wendum","year":"2004","unstructured":"Wendum D, Masliah J, Trugnan G, Flejou JF (2004) Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch 445:327\u2013333","journal-title":"Virchows Arch"},{"key":"198_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0014-5793(02)02689-3","volume":"518","author":"T Yano","year":"2002","unstructured":"Yano T, Zissel G, Muller-Qernheim J, Shin SJ, Satoh H, Ichikawa T (2002) Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3. FEBS Lett 518:154\u2013158","journal-title":"FEBS Lett"},{"key":"198_CR36","first-page":"3971","volume":"7","author":"K Yoshimatsu","year":"2001","unstructured":"Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson PJ, DeLellis RA, Subbaramaiah K, Dannenberg AJ (2001) Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 7:3971\u20133976","journal-title":"Clin Cancer Res"},{"key":"198_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.06.014","volume":"215","author":"S Zha","year":"2004","unstructured":"Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM (2004) Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215:1\u201320","journal-title":"Cancer Lett"},{"key":"198_CR38","first-page":"6706","volume":"62","author":"BS Zweifel","year":"2002","unstructured":"Zweifel BS, Davis TW, Ornberg RL, Masferrer JL (2002) Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res 62:6706\u20136711","journal-title":"Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-006-0198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-006-0198-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-006-0198-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:33:56Z","timestamp":1559079236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-006-0198-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s00428-006-0198-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,12]]}}}